0001562180-24-000365.txt : 20240109
0001562180-24-000365.hdr.sgml : 20240109
20240109160929
ACCESSION NUMBER: 0001562180-24-000365
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gregory Philip D
CENTRAL INDEX KEY: 0001343543
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40791
FILM NUMBER: 24523359
MAIL ADDRESS:
STREET 1: POINT RICHMOND TECH CENTER II
STREET 2: 501 CANAL BOULEVARD SUITE A100
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 2seventy bio, Inc.
CENTRAL INDEX KEY: 0001860782
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863658454
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-01-05
false
0001860782
2seventy bio, Inc.
TSVT
0001343543
Gregory Philip D
60 BINNEY STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Scientific Officer
false
Common Stock
2024-01-05
4
S
false
795.00
3.7536
D
230842.00
D
Common Stock
2024-01-08
4
A
false
79438.00
0.00
A
310280.00
D
Stock Option (Right to buy)
3.97
2024-01-08
4
A
false
158875.00
0.00
A
2034-01-08
Common Stock
158875.00
158875.00
D
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units ("RSUs").
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.675 to $3.83, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
RSU awards vest over a four-year period at the rate of 25% on 01/02/2025, 25% on 01/02/2026, 25% on 01/02/2027, and 25% on 01/02/2028.
This stock option vests over a four-year period at the rate of 25% on 01/02/2025, and then in 36 equal monthly installments thereafter.
/s/ Teresa Jurgensen, Attorney-in-Fact
2024-01-09